SOPHiA GENETICS (SOPH) Net Income towards Common Stockholders (2020 - 2026)

SOPHiA GENETICS has reported Net Income towards Common Stockholders for 6 years, with the latest figure at -$19.2 million in Q4 2025.

• Quarterly Net Income towards Common Stockholders fell 26.53% year-over-year to -$19.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$34.2 million (down 6.43% YoY) and the FY2025 annual result came in at -$79.0 million, down 26.41% from the prior year.
• Net Income towards Common Stockholders grew to -$19.2 million in Q4 2025 per SOPH's latest filing, from -$20.0 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $24.7 million in Q2 2022 and troughed at -$25.5 million in Q1 2022.
• A 5-year average of -$10.7 million and a median of -$17.9 million in 2021 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2021 and 2022: Net Income towards Common Stockholders sank 303.93% in 2021, then surged 234.21% in 2022.
• Over 5 years, Net Income towards Common Stockholders stood at -$21.4 million in 2021, then soared by 34.64% to -$14.0 million in 2022, then tumbled by 72.21% to -$24.1 million in 2023, then soared by 37.0% to -$15.2 million in 2024, then declined by 26.53% to -$19.2 million in 2025.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$19.2 million, -$20.0 million, and $22.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.